These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18433588)

  • 1. [Epidemiology of primary and secondary liver cancers].
    Jepsen P; Kissmeyer-Nielsen P
    Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany].
    Schurr R; Stölzel U; Schuppan D; Schwertner C; Steinberg J; Scherübl H
    Dtsch Med Wochenschr; 2006 Jul; 131(30):1649-55. PubMed ID: 16850381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
    Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
    Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in primary liver cancer in the UK, 1979-94.
    Taylor-Robinson SD; Foster GR; Arora S; Hargreaves S; Thomas HC
    Lancet; 1997 Oct; 350(9085):1142-3. PubMed ID: 9343506
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
    Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
    J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
    Parkin DM; Ohshima H; Srivatanakul P; Vatanasapt V
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):537-44. PubMed ID: 8268770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma: update and future perspectives.
    Gatto M; Bragazzi MC; Semeraro R; Napoli C; Gentile R; Torrice A; Gaudio E; Alvaro D
    Dig Liver Dis; 2010 Apr; 42(4):253-60. PubMed ID: 20097142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary liver cancer in Sri Lanka.
    Nagaratnam N; Ramachandra V; Jiffry AJ; Bhuvanendran N
    J Trop Med Hyg; 1984 Aug; 87(4):185-7. PubMed ID: 6097698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.
    Luke C; Price T; Roder D
    Asian Pac J Cancer Prev; 2010; 11(6):1479-85. PubMed ID: 21338184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
    Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2014 Apr; 139(2):184-92. PubMed ID: 24777600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of liver cancer: an overview.
    Srivatanakul P; Sriplung H; Deerasamee S
    Asian Pac J Cancer Prev; 2004; 5(2):118-25. PubMed ID: 15244512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic sphincterotomy and long-term risk of cholangiocarcinoma: a population-based follow-up study.
    Mortensen FV; Jepsen P; Tarone RE; Funch-Jensen P; Jensen LS; Sørensen HT
    J Natl Cancer Inst; 2008 May; 100(10):745-50. PubMed ID: 18477806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.